Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yu-yun Shao Kun-Huei Yeh Ann-Lii Cheng |
| Publication date | May 24, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |